Anaemia prevalence · people at risk of malaria
Non‐pyrethroid‐like indoor residual spraying (IRS) plus… showed no clear difference in anaemia prevalence compared with ITNs alone (low certainty).
1 finding from 1 review
RR 0.71 [0.38, 1.31]
4288 participants
Low
Intervention not reported
Anaemia prevalence · children and adults at risk of malaria
The intervention leads to lower anaemia prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Anaemia · Pregnant women (parity 2+)
1 finding from 1 review
Intervention not reported
Anaemia · Pregnant women (parity 0‐1)
The intervention leads to lower anaemia (high certainty).
1 finding from 1 review
Intervention not reported
Anaemia · Pregnant women (all parities)
The intervention showed no clear difference in anaemia (moderate certainty).
1 finding from 1 review
Intervention not reported
Anaemia · Pregnant women (parity 0‐1)
The intervention probably leads to lower anaemia (moderate certainty).
1 finding from 1 review
Anaemia prevalence (haemoglobin < 8 g/dL) · people at risk of malaria
Pyrethroid‐like indoor residual spraying (IRS) + insecticide‐treated… showed no clear difference in anaemia prevalence (haemoglobin < 8 g/dL) compared with ITNs alone (low certainty).
1 finding from 1 review
RR 1.12 [0.89, 1.4]
4186 participants
Low
Intervention not reported
Anaemia · malaria in infants
The intervention showed no clear difference in anaemia (moderate certainty).
1 finding from 1 review
Intervention not reported
Anaemia · malaria in infants
1 finding from 1 review
Intervention not reported
Anaemia · malaria in infants
The intervention showed no clear difference in anaemia (moderate certainty).
1 finding from 1 review
Intervention not reported
Anaemia · children under 12 months of age
The intervention probably leads to lower anaemia (moderate certainty).
1 finding from 1 review
Intervention not reported
Anaemia · adults and children with confirmed clinical and parasitological P vivax malaria
It is very uncertain whether the intervention changes anaemia (very low certainty).
1 finding from 1 review
Maternal anaemia at delivery · HIV‐infected pregnant women
Mefloquine plus cotrimoxazole showed no clear difference in maternal anaemia at delivery compared with cotrimoxazole (moderate certainty).
1 finding from 1 review
Maternal anaemia at delivery · HIV‐uninfected pregnant women
Mefloquine probably leads to lower maternal anaemia at delivery compared with sulfadoxine‐pyrimethamine (moderate certainty).
1 finding from 1 review
Intervention not reported
Severe anaemia During the third trimester · Pregnant women (parity 2+)
The intervention showed no clear difference in severe anaemia During the third trimester (low certainty).
1 finding from 1 review
Intervention not reported
Severe anaemia During the third trimester · Pregnant women (parity 0‐1)
The intervention leads to lower severe anaemia During the third trimester (high certainty).
1 finding from 1 review
Intervention not reported
Severe anaemia During the third trimester · Pregnant women (all parities)
The intervention may leads to lower severe anaemia During the third trimester (low certainty).
1 finding from 1 review
Intervention not reported
Severe anaemia During the third trimester · Pregnant women (parity 0‐1)
The intervention leads to lower severe anaemia During the third trimester (high certainty).
1 finding from 1 review
Intervention not reported
Maternal anaemia (Hb < 11 g/dL at delivery) · HIV‐positive pregnant women living
The intervention showed no clear difference in maternal anaemia (Hb < 11 g/dL at delivery) (low certainty).
1 finding from 1 review
Intervention not reported
Maternal anaemia (Hb < 11 g/dL at delivery) · HIV‐positive pregnant women
It is very uncertain whether the intervention changes maternal anaemia (Hb < 11 g/dL at delivery) (very low certainty).
1 finding from 1 review